Find Funding Opportunities

This FOA is issued by three NIH Institutes (NINDS, NIMH and NIDA) under the Department of Health and Human Services (HHS) of the United States of America (U.S.) and the Department of Biotechnology (DBT) under the Ministry of Science and Technology (MoST) of the Republic of India (India). The purpose of this program is to support the establishment and enhancement of bilateral research collaborations between U.S. and Indian investigators in the field of neuroscience with an emphasis on understanding, treating and curing neurological, mental and addictive disorders. Specific areas of research may include, but are not limited to, studies of mechanisms underlying neurological, mental and addictive disorders and diseases, planning for population-based research and clinical trials, the development of infrastructures for resource, tool and data sharing in addition to projects aimed at advancing global health research, particularly as it relates to the mission of the participating organizations.

The purpose of this funding opportunity announcement (FOA) is to support innovative investigator-initiated R01 applications using animal models in conjunction with translational/clinical approaches that take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify the specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations. Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NIHCD's Birth Defects Initiative.

This FOA solicits Research Education Grant (R25) applications to develop and implement short courses on neurotherapeutics development for academic neuroscientists. The short courses should provide participants with a sufficient overview of the neurotherapeutics development process to (1) understand the steps required for therapeutics development, (2) anticipate and overcome common challenges in the process, and (3) interact effectively with collaborators who have expertise in various aspects of therapeutics development. The short courses should primarily target independent academic neuroscience researchers and senior post-doctoral fellows interested in incorporating treatment development into their research programs.

The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications to participate as a Clinical Site in the Network for Excellence in Neuroscience Clinical Trials. This clinical research network will develop and conduct multiple, scientifically sound, possibly biomarker-informed exploratory clinical trials evaluating the most promising therapies, whether from academic, foundation or industry discoveries.Examples include Phase 2 clinical trials and clinical research studies aimed at validating biomarkers and clinical outcomes in preparation for clinical trials. The network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network will not be specific to one disease, it will have the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in response to disease-specific opportunities. This FOA solicits applications for Clinical Sites. Separate FOAs solicit applications for the Clinical Coordinating Center and the Data Coordinating Center (RFA-NS-11-009 and RFA-NS-11-010).

The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications to participate as a Clinical Coordinating Center in the Network for Excellence in Neuroscience Clinical Trials. This clinical research network will develop and conduct multiple, scientifically sound, possibly biomarker-informed exploratory clinical trials evaluating the most promising therapies, whether from academic, foundation or industry discoveries.Examples include Phase 2 clinical trials and clinical research studies aimed at validating biomarkers and clinical outcomes in preparation for clinical trials. The network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network will not be specific to one disease, it will have the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in response to disease-specific opportunities. This FOA solicits applications for the Clinical Coordinating Center (CCC). Separate FOAs solicit applications for the Clinical Sites and the Data Coordinating Center (RFA-NS-11-008 and RFA-NS-11-010).

The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications to participate as a Data Coordinating Center in the Network for Excellence in Neuroscience Clinical Trials. This clinical research network will develop and conduct multiple, scientifically sound, possibly biomarker-informed exploratory clinical trials evaluating the most promising therapies, whether from academic, foundation or industry discoveries.Examples include Phase 2 clinical trials and clinical research studies aimed at validating biomarkers and clinical outcomes in preparation for clinical trials. The network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations. While the network will not be specific to one disease, it will have the capacity to coordinate a cadre of specialist investigators to implement studies efficiently in response to disease-specific opportunities. This FOA solicits applications for the Data Coordinating Center (DCC). Separate FOAs solicit applications for the Clinical Sites and the Clinical Coordinating Center (insert links to RFA-NS-008 and RFA-NS-009).

The purpose of the NIH Summer Research Experience Program (referred to as the Summer Research Program) is to provide a high quality research experience for high school and college students and for science teachers during the summer academic break. The NIH expects that such programs will: help attract young students to careers in science; provide opportunities for college students to gain valuable research experience to help prepare them for graduate school; and enhance the skills of science teachers and enable them to more effectively communicate the nature of the scientific process to their students. The programs would also contribute to enhancing overall science literacy. Summer Research Programs that expand and complement existing summer educational and training programs are encouraged. Not all participating Institutes and Centers (ICs) support all aspects of this program. Therefore, prospective applicants should contact staff at the relevant IC (see Section VII) to discuss their proposed program.

This NIH Funding Opportunity Announcement (FOA), issued by the NIH Basic Behavioral and Social Science Opportunity Network [OppNet] solicits applications for short-term mentored career development (K18) awards in the basic behavioral and social sciences research (b-BSSR) from three months to one year in duration. The program targets established, mid-career and senior investigators, to support their development of research capability in b-BSSR. Two categories of candidates are targeted: (a) biomedical or clinical researchers with little experience in basic behavioral and social sciences research who seek training with a well established b-BSSR investigator in order to explore the introduction of b-BSSR into their research programs; and (b) investigators in the basic or applied behavioral and social sciences who wish to build new components or domains of basic-BSSR into their research programs. The intent of this FOA is to provide candidates with protected time to achieve a shift in the focus of their research direction in the basic behavioral and social sciences, or to substantially enrich a current b-BSSR research program through the introduction of tools, theories or approaches from another discipline or area of science; it is not intended as a substitute for research project support. This FOA is sponsored by the National Institutes of Health (NIH) Basic Behavioral and Social Science Opportunity Network (OppNet). OppNet strongly encourages investigators to consult NIH-OBSSRs definitions related to b-BSSR for OppNet-related FOAs.

This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop, validate, and/or calibrate informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This funding opportunity will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This solicitation will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. Potential applicants may be interested in FOA (PAR-11-038) Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) issued simultaneously with this FOA.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage linked cooperative agreement (U01) applications from large, multidisciplinary groups of investigators to accelerate the rate of progress in identifying the genetic factors that contribute to epilepsy syndromes. Linked applications may include an administrative core, a genetics core, and specific scientific projects proposed for the initial performance period of the Center without Walls.